Back to Search Start Over

Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health

Authors :
EFSA Scientific Committee
Simon More
Vasileios Bampidis
Diane Benford
Claude Bragard
Thorhallur Halldorsson
Antonio Hernández‐Jerez
Susanne Hougaard Bennekou
Kostas Koutsoumanis
Claude Lambré
Kyriaki Machera
Hanspeter Naegeli
Søren Nielsen
Josef Schlatter
Dieter Schrenk
Vittorio Silano (deceased)
Dominique Turck
Maged Younes
Jacqueline Castenmiller
Qasim Chaudhry
Francesco Cubadda
Roland Franz
David Gott
Jan Mast
Alicja Mortensen
Agnes G. Oomen
Stefan Weigel
Eric Barthelemy
Ana Rincon
José Tarazona
Reinhilde Schoonjans
Source :
EFSA Journal, Vol 19, Iss 8, Pp n/a-n/a (2021)
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

Abstract The EFSA has updated the Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain, human and animal health. It covers the application areas within EFSA’s remit, including novel foods, food contact materials, food/feed additives and pesticides. The updated guidance, now Scientific Committee Guidance on nano risk assessment (SC Guidance on Nano‐RA), has taken account of relevant scientific studies that provide insights to physico‐chemical properties, exposure assessment and hazard characterisation of nanomaterials and areas of applicability. Together with the accompanying Guidance on Technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles (Guidance on Particle‐TR), the SC Guidance on Nano‐RA specifically elaborates on physico‐chemical characterisation, key parameters that should be measured, methods and techniques that can be used for characterisation of nanomaterials and their determination in complex matrices. The SC Guidance on Nano‐RA also details aspects relating to exposure assessment and hazard identification and characterisation. In particular, nanospecific considerations relating to in vitro/in vivo toxicological studies are discussed and a tiered framework for toxicological testing is outlined. Furthermore, in vitro degradation, toxicokinetics, genotoxicity, local and systemic toxicity as well as general issues relating to testing of nanomaterials are described. Depending on the initial tier results, additional studies may be needed to investigate reproductive and developmental toxicity, chronic toxicity and carcinogenicity, immunotoxicity and allergenicity, neurotoxicity, effects on gut microbiome and endocrine activity. The possible use of read‐across to fill data gaps as well as the potential use of integrated testing strategies and the knowledge of modes or mechanisms of action are also discussed. The Guidance proposes approaches to risk characterisation and uncertainty analysis.

Details

Language :
English
ISSN :
18314732
Volume :
19
Issue :
8
Database :
Directory of Open Access Journals
Journal :
EFSA Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.0383c8edd0f64cd398b385c33297384e
Document Type :
article
Full Text :
https://doi.org/10.2903/j.efsa.2021.6768